A PYMNTS Company

Drug distributor McKesson settles Medicaid fraud case with major payout

By  |  July 29, 2012

The biggest drug distributor in the United States, McKesson Corp., has agreed to pay a combined $151 million to 29 states to settle claims that it inflated drug prices reported to state Medicaid programs. Prices provided to First Data Bank, whose index is used to determine drug pricing for those programs, were inflated by as much as 25%. California, which will receive a $23.5 million share of the settlement, reported the price-gouging went on from August 2001 to December 2009.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full content: MarketWatch

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

     

    Related content: Health Care Reform, Provider Affiliations, and Antitrust Risks 

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.